|
|
|
|
154 * !
|
Tue, 8/4/2020,
10:00 AM -
11:50 AM
|
Virtual
|
|
Integrating Real World Data with Clinical Trials: Opportunities and Challenges — Topic Contributed Papers
|
|
Caucus for Women in Statistics, ENAR, Biopharmaceutical Section
|
|
Organizer(s): Yimei Li, University of Pennsylvania
|
|
Chair(s): Yimei Li, University of Pennsylvania
|
|
10:05 AM
|
An Integrated Analysis of Randomized Clinical Trials and Real World Evidence Studies: Theory and Application
Xiaofei Wang, Duke University; Shu Yang, North Carolina State University
|
|
10:25 AM
|
Synthesizing External Aggregated Information in the Presence of Population Heterogeneity: A Penalized Empirical Likelihood Approach
Mi-Ok Kim, UCSF
|
|
10:45 AM
|
Multiple Imputation Strategies for Handling Missing Data When Transporting Randomized Clinical Trial Findings Using Propensity Score-Based Methodologies
Albee Ling, Stanford University; Maria Montez-Rath, Stanford University; Kris Kapphahn, Stanford University; Maya Mathur, Stanford University; Manisha Desai, Stanford University
|
|
11:05 AM
|
Evaluating the Use of Real-World Data as a Source for Full or Hybrid Control Arms for Clinical Trials
Douglas Faries, Lilly Research Laboratories; Zhanglin Cui, Eli Lilly and Company
|
|
11:25 AM
|
COMET: An Active Surveillance Trial in Low Risk DCIS, Challenges and Integration with National Cancer Database
Terry Hyslop, Biostat and Bioinformatics
|
|
11:45 AM
|
Floor Discussion
|
